Gene polymorphisms and musculoskeletal disease

[1]  Y. Choi,et al.  Association of vitamin D receptor and estrogen receptor gene polymorphisms with bone mass in postmenopausal Korean women , 2001, Menopause.

[2]  T. Ogihara,et al.  Calcitonin Receptor Gene Polymorphism in Japanese Women: Correlation with Body Mass and Bone Mineral Density , 2001, Calcified Tissue International.

[3]  B. Yoo,et al.  Lack of relationship between vitamin D receptor polymorphism and bone erosion in rheumatoid arthritis. , 2001, Journal of Korean medical science.

[4]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[5]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[6]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[7]  J. Eisman,et al.  ApaI polymorphisms of the vitamin D receptor predict bone density of the lumbar spine and not racial difference in bone density in young men. , 2001, The Journal of laboratory and clinical medicine.

[8]  D. Reid,et al.  Estrogen Receptor α Gene Polymorphisms and Bone Mineral Density: Haplotype Analysis in Women from the United Kingdom , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  J. Hay.  Vitamin D receptor polymorphism and posttransplantation bone loss , 2001, Liver transplantation.

[10]  J. Lanchbury,et al.  Interferon gamma gene in rheumatoid arthritis , 2000, The Lancet.

[11]  A. Goris,et al.  Interferon gamma gene in rheumatoid arthritis , 2000, The Lancet.

[12]  M. Muto,et al.  Lack of Association Between Promoter Polymorphism of the Tumor Necrosis Factor-α Gene and Psoriatic Arthritis in Japanese Patients , 2000 .

[13]  H. Hirao,et al.  Vitamin D receptor gene polymorphism is associated with serum total and ionized calcium concentration , 2000, Journal of Molecular Medicine.

[14]  Y. Ouchi,et al.  Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus , 2000, Journal of Human Genetics.

[15]  C. Salvarani,et al.  Interleukin-1 cluster and tumor necrosis factor-α gene polymorphisms in polymyalgia rheumatica , 2000 .

[16]  J. Sieper,et al.  Association of genotypes affecting the expression of interleukin-1beta or interleukin-1 receptor antagonist with osteoarthritis. , 2000, Arthritis and rheumatism.

[17]  G. Malerba,et al.  Association of CTR and COLIA1 Alleles with BMD Values in Peri- and Postmenopausal Women , 2000, Calcified Tissue International.

[18]  P. Lakatos,et al.  Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women. , 2000, Bone.

[19]  I. Gray,et al.  Single nucleotide polymorphisms as tools in human genetics. , 2000, Human molecular genetics.

[20]  D. Lacaille,et al.  Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis , 2000, The Lancet.

[21]  D. Kang,et al.  Association of the vitamin D receptor start codon polymorphism (FokI) with bone mineral density in postmenopausal Korean women , 2000, Journal of Human Genetics.

[22]  M. Brandi,et al.  Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. , 2000, Human molecular genetics.

[23]  J. Nolla,et al.  Influence of vitamin D receptor gene polymorphism on bone mineral density in primary biliary cirrhosis. , 2000, Gastroenterology.

[24]  C. Navarrete,et al.  Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. , 2000, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[25]  R. Francis,et al.  Vitamin D receptor gene start codon polymorphism (FokI) and bone mineral density in healthy male subjects , 2000, Clinical endocrinology.

[26]  A. Ho,et al.  PvuII Polymorphisms of the Estrogen Receptor α and Bone Mineral Density in Healthy Southern Chinese Women , 2000, Calcified Tissue International.

[27]  E. G. de la Concha,et al.  Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[28]  D. Horsman,et al.  Identification of four novel dinucleotide repeat polymorphisms in the TNF-α and TNF-β genes , 2000 .

[29]  S. Chanprasertyothin,et al.  Oestrogen‐receptor‐α gene polymorphism affects response in bone mineral density to oestrogen in post‐menopausal women , 2000 .

[30]  E. Schwarz,et al.  Anti-TNF-α therapy as a clinical intervention for periprosthetic osteolysis , 2000, Arthritis research.

[31]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[32]  Y. Ouchi,et al.  Association of Estrogen Receptor β Gene Polymorphism with Bone Mineral Density , 2000 .

[33]  T. Järvinen,et al.  Vitamin D and Estrogen Receptor Polymorphisms and Bone Mineral Changes in Postpartum Women , 2000, Calcified Tissue International.

[34]  E. Eriksen,et al.  Osteoporotic Fractures Are Associated with an 86‐Base Pair Repeat Polymorphism in the Interleukin‐1‐Receptor Antagonist Gene But Not with Polymorphisms in the Interleukin‐1β Gene , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  T. Griffin,et al.  Single-nucleotide polymorphism analysis by MALDI-TOF mass spectrometry. , 2000, Trends in biotechnology.

[36]  Y. Bagger,et al.  No major effect of estrogen receptor gene polymorphisms on bone mineral density or bone loss in postmenopausal Danish women. , 2000, Bone.

[37]  T. Sasazuki,et al.  Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes. , 1999, Arthritis and rheumatism.

[38]  C. Verweij.  Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis , 1999, Annals of the rheumatic diseases.

[39]  F. Breedveld,et al.  Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritis , 1999, Genes and Immunity.

[40]  R. Allen.  Polymorphism of the human TNF-α promoter — random variation or functional diversity? , 1999 .

[41]  P. Geusens,et al.  Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  J. Dhainaut,et al.  Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. , 1999, JAMA.

[43]  M. Tomita,et al.  Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women. , 1999, American journal of obstetrics and gynecology.

[44]  A. Jullienne,et al.  Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women. , 1998, Human molecular genetics.

[45]  D. Hartl,et al.  Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. , 1998, Tissue antigens.

[46]  S. Chanprasertyothin,et al.  Estrogen receptor gene polymorphism is associated with bone mineral density in premenopausal women but not in postmenopausal women , 1998, Journal of endocrinological investigation.

[47]  M. Brandi,et al.  Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women. , 1998, Biochemical and biophysical research communications.

[48]  C. Bunten,et al.  Bone Mineral Density and Its Change in White Women: Estrogen and Vitamin D Receptor Genotypes and Their Interaction , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  Y. Ouchi,et al.  Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. , 1997, Bone.

[50]  L. Abraham,et al.  The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .

[51]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  X. Ding,et al.  Heat shock inhibits the hypoxia-induced effects on iodide uptake and signal transduction and enhances cell survival in rat thyroid FRTL-5 cells. , 1996, Thyroid : official journal of the American Thyroid Association.

[53]  Y. Ouchi,et al.  Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. , 1995, Biochemical and biophysical research communications.

[54]  J. Witte,et al.  Genetic dissection of complex traits. , 1994, Nature genetics.

[55]  F. Mcduffie.  Arthritis foundation Medical Director's page , 1988 .

[56]  A. Pontiroli,et al.  More on nomifensine , 1985, Journal of endocrinological investigation.

[57]  Li Nianguo,et al.  Biogas in China , 1984 .

[58]  J W Frymoyer,et al.  Failed Lumbar Disc Surgery Requiring Second Operation: A Long-Term Follow-Up Study , 1978, Spine.

[59]  R. Freyberg,et al.  Clinical Studies of Phenylbutazone (Butazolidin) and Butapyrin (Irgapyrin) in Rheumatoid Arthritis, Rheumatoid Spondylitis, and Gout * , 1953, Annals of the rheumatic diseases.

[60]  A. Silman,et al.  Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians. , 2001, Arthritis and rheumatism.

[61]  L. Hocking,et al.  Evaluation of the role of RANK and OPG genes in Paget's disease of bone. , 2001, Bone.

[62]  J. Lacki,et al.  TNF-α gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis , 2000, Rheumatology International.

[63]  S. Hukuda,et al.  Vitamin D receptor gene polymorphisms and osteoarthritis of the hand, hip, and knee: acase-control study in Japan. , 2000, Rheumatology.

[64]  S. Boonen,et al.  Polymorphisms of the VDR, ER and COLIA1 Genes and Osteoporotic Hip Fracture in Elderly Postmenopausal Women , 2000, Osteoporosis International.

[65]  A. Darvasi,et al.  New technologies and DNA resources for high throughput biology. , 1999, British medical bulletin.

[66]  I. Han,et al.  Non-association of Estrogen Receptor Genotypes with Bone Mineral Density and Bone Turnover in Korean Pre-, Peri-, and Postmenopausal Women , 1999, Osteoporosis International.

[67]  R. Recker,et al.  Association of VDR and Estrogen Receptor Genotypes with Bone Mass in Postmenopausal Caucasian Women: Different Conclusions with Different Analyses and the Implications , 1999, Osteoporosis International.

[68]  C. Johannes,et al.  The Effect of the Menopausal Transition and Aging on DHEAS LEvels in Women: S-2. , 1996 .